High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma

하상윤; 송대현; 이재준; 이현우; 조수연; 박철근

추천

검색

자료유형: 학술저널

저자정보: 하상윤 송대현 이재준 이현우 조수연 박철근

저널정보: 거트앤리버 발행위원회 Gut and Liver Gut and Liver 제8권 제6호

발행연도: 2014.1

수록면: 648 - 654 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background/Aims: Upregulation of aldo-keto reductase 1B10 (AKR1B10) through the mitogenic activator protein-1 signaling pathway might promote hepatocarcinogenesis and tumor progression. The goal of this study was to evaluate the prognostic significance of AKR1B10 protein expression in pa-tients with hepatocellular carcinoma after surgery. Methods: A tissue microarray was used to detect the expression level of AKR1B10 protein in tumors from 255 patients with hepa-tocellular carcinoma who underwent curative hepatectomy. The impact of AKR1B10 expression on the survival of pa-tients was analyzed. The median follow-up period was 119.8 months. Results: High AKR1B10 protein expression was observed in 125 of the 255 patients with hepatocellular car-cinoma (49.0%). High AKR1B10 expression was significantly associated with a lack of invasion of the major portal vein (p=0.022), a lack of intrahepatic metastasis (p=0.010), lower the American Joint Committee on Cancer T stage (p=0.016), lower the Barcelona Clinic Liver Cancer stage (p=0.006), and lower α-fetoprotein levels (p=0.020). High AKR1B10 ex-pression was also correlated with a lack of early recurrence (p=0.022). Multivariate analyses of survival revealed that intrahepatic metastases and lower albumin levels were inde-pendent predictors of both shorter recurrence-free survival and shorter disease-specific survival. High AKR1B10 expres-sion was an independent predictor of both longer recurrence-free survival (p=0.024) and longer disease-specific survival (p=0.046). Conclusions: High AKR1B10 protein expression might be useful as a marker of a favorable prognosis in pa-tients with hepatocellular carcinoma after curative hepatec-tomy.

#AKR1B10 #Carcinoma #hepatocellular #Survival

참고문헌 (24)

참고문헌 신청

Barski OA / 2008 / The aldo-keto reductase superfamily and its role in drug metabolism and detoxification / Drug Metab Rev 40 : 553 ~ 624

Cao D / 1998 / Identification and characterization of a novel human aldose reductase-like gene / J Biol Chem 273 : 11429 ~ 11435

Edge SB / 2010 / AJCC cancer staging manual / Springer

Edmondson HA / 1954 / Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies / Cancer 7 : 462 ~ 503

Fukumoto S / 2005 / Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers’ non-small cell lung carcinomas / Clin Cancer Res 11 :